AU2003241131A8 - Methods and systems for management of alzheimer's disease - Google Patents

Methods and systems for management of alzheimer's disease

Info

Publication number
AU2003241131A8
AU2003241131A8 AU2003241131A AU2003241131A AU2003241131A8 AU 2003241131 A8 AU2003241131 A8 AU 2003241131A8 AU 2003241131 A AU2003241131 A AU 2003241131A AU 2003241131 A AU2003241131 A AU 2003241131A AU 2003241131 A8 AU2003241131 A8 AU 2003241131A8
Authority
AU
Australia
Prior art keywords
alzheimer
disease
management
systems
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241131A
Other versions
AU2003241131A1 (en
Inventor
Alon Shalev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brainsgate Ltd
Original Assignee
Brainsgate Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/294,310 external-priority patent/US7146209B2/en
Application filed by Brainsgate Ltd filed Critical Brainsgate Ltd
Publication of AU2003241131A8 publication Critical patent/AU2003241131A8/en
Publication of AU2003241131A1 publication Critical patent/AU2003241131A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
AU2003241131A 2002-06-14 2003-06-13 Methods and systems for management of alzheimer's disease Abandoned AU2003241131A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38893102P 2002-06-14 2002-06-14
US60/388,931 2002-06-14
US10/294,310 2002-11-14
US10/294,310 US7146209B2 (en) 2000-05-08 2002-11-14 Stimulation for treating eye pathologies
PCT/IL2003/000508 WO2003105658A2 (en) 2002-06-14 2003-06-13 Methods and systems for management of alzheimer's disease

Publications (2)

Publication Number Publication Date
AU2003241131A8 true AU2003241131A8 (en) 2003-12-31
AU2003241131A1 AU2003241131A1 (en) 2003-12-31

Family

ID=29739267

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241131A Abandoned AU2003241131A1 (en) 2002-06-14 2003-06-13 Methods and systems for management of alzheimer's disease

Country Status (4)

Country Link
EP (1) EP1521614A2 (en)
AU (1) AU2003241131A1 (en)
CA (1) CA2489341A1 (en)
WO (1) WO2003105658A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2408097A1 (en) 2000-05-08 2001-11-15 Brainsgate Ltd. Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
US7684859B2 (en) 2002-04-25 2010-03-23 Brainsgate Ltd. Stimulation of the OTIC ganglion for treating medical conditions
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US7499748B2 (en) 2005-04-11 2009-03-03 Cardiac Pacemakers, Inc. Transvascular neural stimulation device
US7616990B2 (en) * 2005-10-24 2009-11-10 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
EP2289909B1 (en) 2005-11-30 2014-10-29 AbbVie Inc. Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
CN102898519B (en) 2005-11-30 2015-10-28 Abbvie公司 Monoclonal antibody of anti-amyloid beta protein and uses thereof
US7965180B2 (en) 2006-09-28 2011-06-21 Semiconductor Energy Laboratory Co., Ltd. Wireless sensor device
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
US7860569B2 (en) 2007-10-18 2010-12-28 Brainsgate, Ltd. Long-term SPG stimulation therapy for prevention of vascular dementia
EP2470131B1 (en) 2009-08-24 2014-11-12 New Phase Ltd Phase-change materials
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
CA2808187A1 (en) 2010-08-14 2012-02-23 Abbvie Inc. Amyloid-beta binding proteins
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3226819B1 (en) 2014-11-25 2018-10-24 New Phase Ltd. Phase-change nanoparticle
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
WO2018221244A1 (en) * 2017-05-30 2018-12-06 森永乳業株式会社 Composition for improving brain function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287793B1 (en) 1988-08-19 2001-09-11 Elan Pharmaceuticals, Inc. Diagnostic methods for alzheimer's disease
US5735817A (en) * 1995-05-19 1998-04-07 Shantha; T. R. Apparatus for transsphenoidal stimulation of the pituitary gland and adjoining brain structures
US6325475B1 (en) * 1996-09-06 2001-12-04 Microfab Technologies Inc. Devices for presenting airborne materials to the nose
US6338715B1 (en) * 1999-03-31 2002-01-15 Microfab Technologies, Inc. Digital olfactometer and method for testing olfactory thresholds

Also Published As

Publication number Publication date
EP1521614A2 (en) 2005-04-13
WO2003105658A3 (en) 2004-03-18
WO2003105658A2 (en) 2003-12-24
CA2489341A1 (en) 2003-12-24
AU2003241131A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
AU2003241131A8 (en) Methods and systems for management of alzheimer's disease
AU2003284968A8 (en) Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
EP1575527A4 (en) Medical information management system and method
AU2003219689A8 (en) Method and system for risk-modulated diagnosis of disease
EP1506497A4 (en) Database system and methods
AU2002357340A8 (en) Method and system for integrated asset management
AU2003284878A8 (en) Systems and methods for clinical trials information management
AU2002312066A1 (en) Health care management system and method
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
ITMI20031696A1 (en) COUPLE DISTRIBUTOR FOR VEHICLES AND PROCEDURE
AU2003220096A1 (en) Methods for alzheimer's disease treatment and cognitive enhancement
AU2003223579A8 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2003219925A1 (en) System and method for managing organization's resources
AU2003296341A8 (en) System and method for treating Parkinson's Disease and other movement disorders
AU2003259909A8 (en) Method and system for states of beings configuration management
AU2003277010A1 (en) A method and system for detecting the effects of alzheimer's disease in the human retina
AU2003230667A8 (en) Medical management system and method
AU2003303141A1 (en) Hydroxypropyl amides for the treatment of alzheimer's disease
AU2002336999A1 (en) Model of autoimmune disease and methods for identifying agents against autoimmune disease
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
PL377041A1 (en) System and method for administering permission for use of information
IL172690A0 (en) Methods for the diagnosis and prognosis of alzheimer's disease
PL377110A1 (en) Prevention and treatment of alzheimer's disease
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
AU2003251962A8 (en) Screening for alzheimer's disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase